KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Oct 16, 2026 >>  ABB India 6816  [ -0.13% ]  ACC 1186.95  [ 4.31% ]  Ambuja Cements 362.9  [ 3.98% ]  Asian Paints 2333  [ -1.00% ]  Axis Bank 1286.45  [ -0.16% ]  Bajaj Auto 10417  [ 0.52% ]  Bank of Baroda 230  [ 0.83% ]  Bharti Airtel 1905  [ 2.86% ]  Bharat Heavy 434.1  [ -0.14% ]  Bharat Petroleum 294  [ 0.15% ]  Britannia Industries 4780  [ -2.32% ]  Cipla 1325  [ -0.65% ]  Coal India 416.9  [ -0.50% ]  Colgate Palm 1772.55  [ -0.53% ]  Dabur India 386  [ 0.26% ]  DLF 674  [ 0.66% ]  Dr. Reddy's Lab. 1231.85  [ 0.91% ]  GAIL (India) 168.25  [ -0.27% ]  Grasim Industries 2921  [ 0.62% ]  HCL Technologies 1378  [ 1.08% ]  HDFC Bank 728.1  [ -0.06% ]  Hero MotoCorp 5230  [ 0.57% ]  Hindustan Unilever 1898  [ 0.20% ]  Hindalco Industries 910  [ 1.79% ]  ICICI Bank 1396.8  [ 0.13% ]  Indian Hotels Co. 772  [ 4.32% ]  IndusInd Bank 874  [ -1.24% ]  Infosys 1161.6  [ 4.55% ]  ITC 263  [ -0.66% ]  Jindal Steel 1040.4  [ 1.01% ]  Kotak Mahindra Bank 446  [ -0.63% ]  L&T 3632  [ -0.66% ]  Lupin 1955.8  [ -0.17% ]  Mahi. & Mahi 2920  [ 2.38% ]  Maruti Suzuki India 11482  [ 0.50% ]  MTNL 23.53  [ -0.34% ]  Nestle India 1265  [ -1.17% ]  NIIT 85.39  [ -2.03% ]  NMDC 71.7  [ 1.10% ]  NTPC 316.5  [ 0.76% ]  ONGC 222.2  [ -1.20% ]  Punj. NationlBak 116.1  [ 0.78% ]  Power Grid Corpn. 250.95  [ 0.38% ]  Reliance Industries 1210  [ -1.09% ]  SBI 961.7  [ 0.02% ]  Vedanta 246.5  [ 0.16% ]  Shipping Corpn. 284.85  [ 0.26% ]  Sun Pharmaceutical 1760  [ -0.03% ]  Tata Chemicals 632.4  [ 0.72% ]  Tata Consumer 977.2  [ -1.70% ]  Tata Motors Passenge 286.9  [ 0.02% ]  Tata Steel 175.6  [ -0.48% ]  Tata Power Co. 353.45  [ 1.19% ]  Tata Consult. Serv. 2463  [ 4.61% ]  Tech Mahindra 1788  [ 8.45% ]  UltraTech Cement 10928  [ 0.58% ]  United Spirits 1376.1  [ -0.71% ]  Wipro 184.4  [ 6.16% ]  Zee Entertainment 72.01  [ -1.02% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    NEULAND LABORATORIES LTD.

    16 October 2026 | 12:00

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE794A01010 BSE Code / NSE Code 524558 / NEULANDLAB Book Value (Rs.) 1,576.07 Face Value 10.00
    Bookclosure 24/07/2026 52Week High 24225 EPS 283.71 P/E 69.35
    Market Cap. 25242.81 Cr. 52Week Low 11500 P/BV / Div Yield (%) 12.48 / 0.17 Market Lot 1.00
    Security Type Other
    • Select another Company

    Quarterly Trends

    Neuland Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202606(3) 202603(3) 202606(3) 202603(3)
    OprtIncome Neuland Laboratories Ltd. 641.58 776.25 Aarey Drugs & Pharmaceuticals Ltd. 44.63 189.47
    OtherRecurrInc Neuland Laboratories Ltd. 8.49 12.46 Aarey Drugs & Pharmaceuticals Ltd. 1.72 -0.43
    Operating profit Neuland Laboratories Ltd. 196.02 281.82 Aarey Drugs & Pharmaceuticals Ltd. 0.48 3.49
    GrossProfit Neuland Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ReportedPAT Neuland Laboratories Ltd. 147.36 212.52 Aarey Drugs & Pharmaceuticals Ltd. 1.02 1.56
    Equity Capital Neuland Laboratories Ltd. 12.90 12.90 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    OPM Neuland Laboratories Ltd. 30.55 36.30 Aarey Drugs & Pharmaceuticals Ltd. 1.06 1.84
    GPM Neuland Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    NPM Neuland Laboratories Ltd. 22.96 0.00 Aarey Drugs & Pharmaceuticals Ltd. 2.29 0.82

    Annual Trends

    Neuland Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OperatingIncome Neuland Laboratories Ltd. 2022.99 1476.84 Aarey Drugs & Pharmaceuticals Ltd. 472.27 473.94
    OperatingProfit Neuland Laboratories Ltd. 573.25 322.30 Aarey Drugs & Pharmaceuticals Ltd. 7.17 2.90
    OtherRecurrInc Neuland Laboratories Ltd. 30.16 20.51 Aarey Drugs & Pharmaceuticals Ltd. 6.10 9.81
    AdjustedPBT Neuland Laboratories Ltd. 487.73 268.97 Aarey Drugs & Pharmaceuticals Ltd. 5.41 6.10
    ReportedPAT Neuland Laboratories Ltd. 363.10 259.43 Aarey Drugs & Pharmaceuticals Ltd. 3.97 4.02
    EquityDividend Neuland Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    EquityCapital Neuland Laboratories Ltd. 12.90 12.90 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    PreferenceCapital Neuland Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ResAndSurplus Neuland Laboratories Ltd. 1852.11 1504.05 Aarey Drugs & Pharmaceuticals Ltd. 121.97 107.51
    LoanFunds Neuland Laboratories Ltd. 196.61 136.01 Aarey Drugs & Pharmaceuticals Ltd. 49.96 34.86
    AL_CurrentLiabilities Neuland Laboratories Ltd. 865.87 524.37 Aarey Drugs & Pharmaceuticals Ltd. 96.86 117.26
    NetBlock Neuland Laboratories Ltd. 1176.91 954.89 Aarey Drugs & Pharmaceuticals Ltd. 25.78 16.22
    Investments Neuland Laboratories Ltd. 2.14 109.37 Aarey Drugs & Pharmaceuticals Ltd. 2.12 2.12
    TotCurrentAssets Neuland Laboratories Ltd. 1538.70 1066.25 Aarey Drugs & Pharmaceuticals Ltd. 269.35 272.26

    Ratios

    Neuland Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OPM Neuland Laboratories Ltd. 28.33 21.82 Aarey Drugs & Pharmaceuticals Ltd. 1.51 0.61
    NPM Neuland Laboratories Ltd. 17.94 17.56 Aarey Drugs & Pharmaceuticals Ltd. 0.84 0.84
    Reported EPS Neuland Laboratories Ltd. 283.01 202.20 Aarey Drugs & Pharmaceuticals Ltd. 1.39 1.43
    Return on Networth Neuland Laboratories Ltd. 19.46 17.10 Aarey Drugs & Pharmaceuticals Ltd. 2.63 2.95
    Debt/ Equity Neuland Laboratories Ltd. 0.10 0.08 Aarey Drugs & Pharmaceuticals Ltd. 0.33 0.25
    Financial Charges Coverage Ratio Neuland Laboratories Ltd. 25.20 41.32 Aarey Drugs & Pharmaceuticals Ltd. 2.65 2.73
    Current Ratio Neuland Laboratories Ltd. 1.78 2.03 Aarey Drugs & Pharmaceuticals Ltd. 2.78 2.32
    Dividend per share Neuland Laboratories Ltd. 34.00 12.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00

    Shriram Financial Services Private Limited (Formerly known as Way2Wealth Brokers Pvt. Ltd.) - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Shriram Financial Services Pvt. Ltd. (Formerly known as Way2Wealth Brokers Pvt. Ltd.) All rights reserved

    Designed, developed and content provided by  Dion
    Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & Quick
    A. Register On SCORES / SMARTODR Portal
    B. Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
    C. Benefits:

    i. Effective Communication

    ii. Speedy Redressal of Grievance / Dispute